Compare AbCellera Biologics Inc (ABCL) vs Angi Inc (ANGI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs Angi Inc — how do they compare? AbCellera Biologics Inc trades at $9.2 (market cap $2.99B), while Angi Inc trades at $4.5 (market cap $182.30M). The key difference: AbCellera Biologics Inc is far larger — about 16.4× Angi Inc's market cap, and AbCellera Biologics Inc is trading nearer its 52-week high, Angi Inc nearer its low. Which is the better fit depends on your goals.
| ABCL | ANGI | |
|---|---|---|
Market Cap | $2.99B | $182.30M |
Sector | Health | Media |
52-Week High | $9.76 | $18.46 |
52-Week Low | $2.78 | $4.49 |
Enterprise Value | $2.58B | $392.07M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Angi Inc
Angi Inc connects quality home service professionals across different categories, from repairing and remodeling to cleaning and landscaping, with consumers. It has two geographical segments namely North America (the United States and Canada), which primarily includes the operations HomeAdvisor, Angie's List, Handy, mHelpDesk, HomeStars, and Fixd Repair
Read more on ANGI →
